Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2009, Article ID 187864, 6 pages
http://dx.doi.org/10.1155/2009/187864
Clinical Study

Detection of Autoantibodies against Recombinant Desmoglein 1 and 3 Molecules in Patients with Pemphigus vulgaris: Correlation with Disease Extent at the Time of Diagnosis and during Follow-Up

1Unit of Dermatology, University of Padua, Via Cesare Battisti 206, 35128 Padua, Italy
2Veneto Institute of Oncology (IOV), IRCCS, Via Gattamelata 64, 35128 Padua, Italy
3Department of Environmental Medicine and Public Health, Via Loredan 18, 35121 Padua, Italy

Received 14 April 2009; Revised 2 July 2009; Accepted 25 September 2009

Academic Editor: Ethan Shevach

Copyright © 2009 Anna Belloni-Fortina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Sitaru and D. Zillikens, “Mechanisms of blister induction by autoantibodies,” Experimental Dermatology, vol. 14, no. 12, pp. 861–875, 2005. View at Publisher · View at Google Scholar · View at PubMed
  2. S. W. Yeh, B. Ahmed, N. Sami, and A. Razzaque Ahmed, “Blistering disorders: diagnosis and treatment,” Dermatologic Therapy, vol. 16, no. 3, pp. 214–223, 2003. View at Publisher · View at Google Scholar
  3. J.-C. Bystryn and J. L. Rudolph, “Pemphigus,” The Lancet, vol. 366, no. 9479, pp. 61–73, 2005. View at Publisher · View at Google Scholar
  4. P. Lenz, M. Amagai, B. Volc-Platzer, G. Stingl, and R. Kirnbauer, “Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool,” Archives of Dermatology, vol. 135, no. 2, pp. 143–148, 1999. View at Google Scholar
  5. M. Amagai, A. Komai, T. Hashimoto et al., “Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus,” British Journal of Dermatology, vol. 140, no. 2, pp. 351–357, 1999. View at Publisher · View at Google Scholar
  6. V. K. Sharma, H. R. Y. Prasad, S. Khandpur, and A. Kumar, “Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris,” International Journal of Dermatology, vol. 45, no. 5, pp. 518–522, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. M. Amagai, K. Tsunoda, D. Zillikens, T. Nagai, and T. Nishikawa, “The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile,” Journal of the American Academy of Dermatology, vol. 40, no. 2, pp. 167–170, 1999. View at Publisher · View at Google Scholar
  8. K. E. Harman, M. J. Gratian, P. T. Seed, B. S. Bhogal, S. J. Challacombe, and M. M. Black, “Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3,” Clinical and Experimental Dermatology, vol. 25, no. 3, pp. 236–240, 2000. View at Publisher · View at Google Scholar
  9. K. E. Harman, P. T. Seed, M. J. Gratian, B. S. Bhogal, S. J. Challacombe, and M. M. Black, “The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels,” British Journal of Dermatology, vol. 144, no. 4, pp. 775–780, 2001. View at Publisher · View at Google Scholar
  10. K. E. Harman, M. J. Gratian, B. S. Bhogal, S. J. Challacombe, and M. M. Black, “A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype,” British Journal of Dermatology, vol. 143, no. 2, pp. 343–348, 2000. View at Publisher · View at Google Scholar
  11. C. Abasq, H. Mouquet, D. Gilbert et al., “ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus,” Archives of Dermatology, vol. 145, no. 5, pp. 529–535, 2009. View at Publisher · View at Google Scholar · View at PubMed
  12. S. W. Cheng, M. Kobayashi, A. Tanikawa, K. Kinoshita-Kuroda, M. Amagai, and T. Nishikawa, “Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3,” British Journal of Dermatology, vol. 147, no. 2, pp. 261–265, 2002. View at Publisher · View at Google Scholar
  13. B. Pigozzi, A. Peserico, L. Schiesari, and M. Alaibac, “Pemphigus foliaceus evolving into pemphigus vulgaris: a probable example of ‘intermolecular epitope spreading’ confirmed by enzyme-linked immunosorbent assay study,” Journal of the European Academy of Dermatology and Venereology, vol. 22, no. 2, pp. 242–244, 2008. View at Publisher · View at Google Scholar · View at PubMed